A number of regulatory experts have spoken out following the proposals published by the UK Office for Health Improvements and Disparities (OHID) last week, which suggested introducing improvement notices to improve adherence to health and nutrition claim regulation (NHCR).
As the FSA struggles to keep up with the rising number of Novel Foods applications in the UK, a regulatory framework review has concluded with five potential options for a system overhaul.
The industry has vehemently rejected a regulatory assessment leading to the ban of ashwagandha in Denmark and defended the ingredient's safety, as an increasing number of member states show concerns.
The industry has vehemently rejected a regulatory assessment leading to the ban of ashwagandha in Denmark and defended the ingredient's safety, as an increasing number of member states show concerns.
cbdMD Anticipates EU Validation in the Coming Weeks cbdMD, Inc. (NYSE American: YCBD, YCBDpA), (the "Company") announced today that it has received validation of its Novel Food application from the